Fig 1: Inhibition of GP96 using specific inhibitor PU-WS13 and siRNA reduces LPS-induced pro-inflammatory cytokine production. BMDMs were isolated from C57BL/6J mice and stimulated with LPS (100 ng/mL) for 2 hours and treated with PU-WS13 (0.5 µM) either alone for 2 hours or before LPS for 1 hour. DMSO-treated cells served as control group (n = 8). RT-PCR was carried out to evaluate the expression of TNF-a (A), IL-6 (B), IL-1ß (C), and MCP-1 (D) and compared with the untreated group. (E) Culture supernatant was evaluated for secreted TNF-a by ELISA. (F) Murine macrophage RAW 264.7 cell line was transiently transfected with GP96 siRNA (100 nM) or negative control siRNA for 48 hours and stimulated with LPS for the final 6 hours. Secreted TNF-a level was measured in culture supernatant by ELISA. Data are presented as mean ± SEM. ***P < 0.001, ****P < 0.0001. Abbreviation: ND, not detected.
Fig 2: Tiep2-deficient mice were more resistant to AOM/DSS-induced tumorigenesis.A The protocol of AOM/DSS-induced CRC. The tumor number was significant lower in Tipe2-deficent AOM/DSS models (B), especially tumors less than 2 mm in diameter (C). Tipe2-defiency showed less severe intestinal morphology (D) accompanied by longer length of the colon (E) in AOM/DSS-induced mice. Tipe2-deficent AOM/DSS models showed lower serum levels of proinflammatory cytokines, such as IL-6 (F), MCP-1 (G), IL-12 (H) and TNF-a (I). Data are representative of three independent experiments and expressed as means ± SEM. Significant difference between two groups was determined using an unpaired two-tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.
Fig 3: Src controls H3 hyperacetylation upon LPS/IFN? stimulation through p300.iNOS expression (a), MCP-1 production (b), and Nos2 and Ccl2 gene expression levels (c) at 16 h post 1 ng/ml LPS/IFN? stimulation in siSrc-treated cells portray Src as an inflammatory gene. Histone acetylation staining in cells treated with siSrc for 48 h (d), and a further 16 h of 1 ng/ml LPS/IFN? stimulation (e) show lower global H3Ac levels with Src knockdown. (f) Total HAT and p300 HAT activity measured in siSrc-treated cells 2 h post LPS/IFN? stimulation show lower p300 HAT activity. Data has been represented as mean ± SEM, and one-way ANOVA with multiple comparisons using Tukey test was performed. Exceptions in panels b–e where only 2 conditions are available were instead subjected to Student’s t-test for analysis. Violin plots show quartiles and median. Source data are provided.
Fig 4: Myeloid-specific GP96 deficiency prevents chronic alcohol-induced endotoxin and pro-inflammatory cytokine production. (A) Endotoxin level was measured in serum (n = 8-12). (B) CyP2e1 was detected in liver microsomal fraction by western blot, and calnexin was used as an internal loading control (n = 3). Total RNA from liver tissue was subjected to quantitative RT-PCR for analysis of pro-inflammatory cytokines TNF-a, IL-6, MCP-1, and IL-1ß; NLRP3; anti-inflammatory markers IL-10, TGF-ß, and ATF3 (C); and macrophage markers (n = 6-10) (F). (D) Total liver protein level for TNF-a was measured in tissue extracts of pair-fed and alcohol-fed mice by ELISA (n = 6-10). (E) ATF3 protein level was analyzed by western blot in whole-liver extracts using tubulin as an internal control (n = 3). The mRNA expression profile of (G) pro-inflammatory, and (H) anti-inflammatory and restorative macrophage markers, Trem2 and ATF3, were analyzed in liver macrophages of pair-fed and alcohol-fed mice (n = 5). (I) The mRNA level of pro-inflammatory cytokines was analyzed in BMDMs isolated from WT and M-GP96KO mice and stimulated with 100 ng/mL LPS for 2 hours (n = 9). Data are represented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Fig 5: Src activation drives H3 hyperacetylation through p300.(a) Effects of PP1 (5 µM) and PP2 (5 µM) treatment on Src activation measured by Western blot. Anti-inflammatory effects of PP1 and PP2 treatments demonstrated by MCP-1 production (b), Ccl2 and Nos2 gene levels (c), and iNOS staining (d) in cells treated with Src inhibitors for 6 h, followed by stimulation of 1 ng/ml LPS/IFN? for 16 h. Global H3Ac levels in cells treated with PP1 and PP2 for 24 h (e), and 6 h Src inhibitors followed by 16 h 1 ng/ml LPS/IFN? treatment (f) show Src inhibition suppress H3Ac expression. (g) p300 activity in unstimulated and stimulated cells wherein 6 h drug treatment was followed by 2 h of 1 ng/ml LPS/IFN? treatment show suppressed p300 activity in PP1- and PP2-treated cells. (h) Ccl2 proximal promoter H3Ac enrichment measured at two different loci in 6 h PP1- and PP2-treated cells that were subsequently stimulated for 2 h with 1 ng/ml LPS/IFN?; ChIP-qPCR with pre-immune IgG displayed background signal and was comparable across conditions (data not shown). (i) Src proximal promoter H3Ac enrichment measured in 6 h PP1- and PP2-treated cells that were subsequently stimulated for 2 h with 1 ng/ml LPS/IFN?. (j) Src gene expression in in 6 h PP1- and PP2-treated cells that were subsequently stimulated for 16 h with 1 ng/ml LPS/IFN?. Data has been represented as mean ± SEM, and one-way ANOVA with multiple comparisons using Tukey test was performed. Violin plots show quartiles and median. Source data and unprocessed blots are provided.
Supplier Page from BioLegend for ELISA MAX(TM) Deluxe Set Mouse MCP-1